1. Home
  2. AROW vs CTMX Comparison

AROW vs CTMX Comparison

Compare AROW & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

N/A

Current Price

$37.06

Market Cap

727.1M

Sector

Finance

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$2.68

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AROW
CTMX
Founded
1851
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.1M
716.9M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
AROW
CTMX
Price
$37.06
$2.68
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
★ $43.50
$12.25
AVG Volume (30 Days)
59.6K
★ 3.6M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 3.26%
N/A
EPS Growth
★ 49.72
N/A
EPS
★ 1.48
N/A
Revenue
N/A
★ $76,201,000.00
Revenue This Year
$24.57
N/A
Revenue Next Year
$16.41
$1.24
P/E Ratio
$25.08
★ $22.58
Revenue Growth
★ N/A
N/A
52 Week Low
$25.91
$2.60
52 Week High
$42.70
$8.21

Technical Indicators

Market Signals
Indicator
AROW
CTMX
Relative Strength Index (RSI) 37.23 37.27
Support Level $35.58 N/A
Resistance Level $37.88 $3.93
Average True Range (ATR) 0.74 0.18
MACD -0.09 -0.01
Stochastic Oscillator 11.99 17.11

Price Performance

Historical Comparison
AROW
CTMX

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: